Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 5:09 PM View:  | Namouni Fouad President, R & D | Blueprint Medicines Corp (BPMC) | 03-Oct-24 | Market Sale | 3,633 | $89.32 | $324,500.00 | (5%) 72.7K to 69.07K | 2% |
| 11-Sep-24 4:06 PM View: | Albers Jeffrey W. Director | Blueprint Medicines Corp (BPMC) | 09-Sep-24 | Sale (Planned) | 9,702 | $85.57 | $830,195.00 | (6%) 167.26K to 157.56K | |
| 11-Sep-24 4:06 PM View: | Albers Jeffrey W. Director | Blueprint Medicines Corp (BPMC) | 09-Sep-24 | Option Exercise | 10,000 | $36.05 | $360,500.00 | 6% 167.26K to 177.26K | |
| 11-Sep-24 4:06 PM View: | Albers Jeffrey W. Director | Blueprint Medicines Corp (BPMC) | 09-Sep-24 | Planned Option Sale | 10,000 | $85.57 | $855,695.00 | (6%) 177.26K to 167.26K | |
| 19-Aug-24 4:00 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 15-Aug-24 | Market Sale (Planned) | 4,409 | $95.23 | $419,869.00 | (6%) 71.62K to 67.21K | 8% |
| 07-Aug-24 5:06 PM View: | Lee Philina Chief Commercial Officer | Blueprint Medicines Corp (BPMC) | 05-Aug-24 | Option Exercise | 41,913 | $67.50 | $2,828,920.00 | 121% 34.73K to 76.64K | |
| 07-Aug-24 5:06 PM View: | Lee Philina Chief Commercial Officer | Blueprint Medicines Corp (BPMC) | 05-Aug-24 | Option Sale | 41,913 | $93.19 | $3,905,870.00 | (55%) 76.64K to 34.73K | |
| 08-Jul-24 4:05 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 05-Jul-24 | Option Exercise | 3,850 | $54.13 | $208,400.00 | 9% 43.76K to 47.61K | |
| 08-Jul-24 4:05 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 05-Jul-24 | Planned Option Sale | 3,850 | $111.20 | $428,120.00 | (8%) 47.61K to 43.76K | |
| 08-Jul-24 4:05 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 03-Jul-24 | Option Exercise | 8,817 | $54.13 | $477,264.00 | 20% 43.76K to 52.58K | |
| 08-Jul-24 4:05 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 03-Jul-24 | Planned Option Sale | 8,817 | $111.29 | $981,244.00 | (17%) 52.58K to 43.76K | |
| 08-Jul-24 7:07 PM View: | Rossi Christina CHIEF OPERATING OFFICER | Blueprint Medicines Corp (BPMC) | 01-Jul-24 | Grant | 9,625 | -- | -- | 15% 64.31K to 73.93K | |
| 08-Jul-24 7:08 PM View: | Carter Percy H. Chief Scientific Officer | Blueprint Medicines Corp (BPMC) | 01-Jul-24 | Grant | 7,500 | -- | -- | 18% 41.9K to 49.4K | |
| 25-Jun-24 4:00 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 21-Jun-24 | Sale (Planned) | 13,552 | $104.19 | $1,411,970.00 | (24%) 57.31K to 43.76K | |
| 25-Jun-24 4:00 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 21-Jun-24 | Option Exercise | 60,482 | $34.48 | $2,085,500.00 | 106% 57.31K to 117.8K | |
| 25-Jun-24 4:00 PM View: | Durso-Bumpus Debra Chief People Officer | Blueprint Medicines Corp (BPMC) | 21-Jun-24 | Planned Option Sale | 60,482 | $104.19 | $6,301,570.00 | (51%) 117.8K to 57.31K | |
| 14-Jun-24 5:38 PM View: | Beckman Daniella Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 26% 8.6K to 10.84K | |
| 14-Jun-24 5:36 PM View: | Tsai John Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 34% 6.5K to 8.74K | |
| 14-Jun-24 5:34 PM View: | Goldberg Mark Alan Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 14% 16.01K to 18.25K | |
| 14-Jun-24 5:41 PM View: | Albers Jeffrey W. Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 1% 165.02K to 167.26K | |
| 14-Jun-24 5:32 PM View: | Dable Habib J Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 34% 6.5K to 8.74K | |
| 14-Jun-24 5:35 PM View: | Seely Lynn Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 20% 11.01K to 13.25K | |
| 14-Jun-24 5:37 PM View: | Coats Lonnel Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 20% 11.01K to 13.25K | |
| 14-Jun-24 5:34 PM View: | Lydon Nicholas Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 4% 55.78K to 58.03K | |
| 14-Jun-24 5:32 PM View: | Borisy Alexis Director | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 3% 71.92K to 74.16K | |
| 07-Jun-24 4:00 PM View: | Carter Percy H. Chief Scientific Officer | Blueprint Medicines Corp (BPMC) | 05-Jun-24 | Private Sale | 4,000 | $105.13 | $420,520.00 | (9%) 45.9K to 41.9K | |
| 06-Jun-24 4:00 PM View: | Hewes L. Becker Chief Medical Officer | Blueprint Medicines Corp (BPMC) | 04-Jun-24 | Private Sale (Planned) | 2,424 | $104.91 | $254,302.00 | (8%) 31.94K to 29.51K | |
| 04-Jun-24 4:00 PM View: | Hewes L. Becker Chief Medical Officer | Blueprint Medicines Corp (BPMC) | 03-Jun-24 | Sale | 1,951 | $106.43 | $207,645.00 | (5%) 36.86K to 34.91K | |
| 05-Jun-24 4:00 PM View: | Carter Percy H. Chief Scientific Officer | Blueprint Medicines Corp (BPMC) | 03-Jun-24 | Private Sale | 2,436 | $106.43 | $259,263.00 | (5%) 48.33K to 45.9K | |
| 04-Jun-24 4:00 PM View: | Hewes L. Becker Chief Medical Officer | Blueprint Medicines Corp (BPMC) | 03-Jun-24 | Sale (Planned) | 2,971 | $106.43 | $316,204.00 | (9%) 34.91K to 31.94K | |
| 04-Jun-24 4:00 PM View: | Hewes L. Becker Chief Medical Officer | Blueprint Medicines Corp (BPMC) | 31-May-24 | Option Exercise | 24,687 | $59.21 | $1,461,650.00 | 53% 46.28K to 70.97K | |
| 04-Jun-24 4:00 PM View: | Hewes L. Becker Chief Medical Officer | Blueprint Medicines Corp (BPMC) | 31-May-24 | Planned Option Sale | 24,687 | $105.91 | $2,614,670.00 | (35%) 70.97K to 46.28K | |
| 04-Jun-24 4:00 PM View: | Hewes L. Becker Chief Medical Officer | Blueprint Medicines Corp (BPMC) | 31-May-24 | Sale (Planned) | 9,421 | $105.91 | $997,806.00 | (20%) 46.28K to 36.86K | |
| 17-May-24 4:05 PM View: | Hurley Ariel Principal Accounting Officer | Blueprint Medicines Corp (BPMC) | 15-May-24 | Option Exercise | 5,856 | $37.69 | $220,736.00 | 39% 14.91K to 20.77K | |
| 17-May-24 4:05 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 15-May-24 | Private Sale (Planned) | 3,850 | $106.95 | $411,772.00 | (5%) 75.47K to 71.62K | |
| 17-May-24 4:05 PM View: | Hurley Ariel Principal Accounting Officer | Blueprint Medicines Corp (BPMC) | 15-May-24 | Planned Option Sale | 5,856 | $106.96 | $626,379.00 | (28%) 20.77K to 14.91K | |
| 10-May-24 4:05 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 08-May-24 | Option Exercise | 28,181 | $2.32 | $65,297.20 | 60% 47.29K to 75.47K | |
| 06-May-24 5:26 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 02-May-24 | Planned Option Sale | 10,000 | $105.00 | $1,050,000.00 | (17%) 57.29K to 47.29K | |
| 06-May-24 5:19 PM View: | Hurley Ariel Principal Accounting Officer | Blueprint Medicines Corp (BPMC) | 02-May-24 | Option Exercise | 1,834 | $54.13 | $99,274.40 | 12% 14.91K to 16.75K | |
| 06-May-24 5:19 PM View: | Hurley Ariel Principal Accounting Officer | Blueprint Medicines Corp (BPMC) | 02-May-24 | Planned Option Sale | 1,834 | $103.88 | $190,516.00 | (11%) 16.75K to 14.91K | |
| 06-May-24 5:26 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 02-May-24 | Option Exercise | 10,000 | $36.05 | $360,500.00 | 21% 47.29K to 57.29K | |
| 01-Apr-24 4:34 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 28-Mar-24 | Option Exercise | 5,000 | $36.05 | $180,250.00 | 11% 47.29K to 52.29K | |
| 01-Apr-24 4:34 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 28-Mar-24 | Planned Option Sale | 5,000 | $95.00 | $475,000.00 | (10%) 52.29K to 47.29K | |
| 22-Mar-24 5:50 PM View: | Albers Jeffrey W. Director | Blueprint Medicines Corp (BPMC) | 20-Mar-24 | Planned Option Sale | 25,073 | $87.28 | $2,188,260.00 | (12%) 201.12K to 176.05K | |
| 22-Mar-24 5:50 PM View: | Albers Jeffrey W. Director | Blueprint Medicines Corp (BPMC) | 20-Mar-24 | Option Exercise | 25,073 | $7.11 | $178,287.00 | 14% 176.05K to 201.12K | |
| 19-Mar-24 5:11 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 15-Mar-24 | Planned Option Sale | 5,000 | $87.78 | $438,913.00 | (8%) 61.02K to 56.02K | |
| 19-Mar-24 4:48 PM View: | Hurley Ariel Principal Accounting Officer | Blueprint Medicines Corp (BPMC) | 15-Mar-24 | Option Exercise | 1,600 | $15.01 | $24,016.00 | 9% 17.86K to 19.46K | |
| 19-Mar-24 4:48 PM View: | Hurley Ariel Principal Accounting Officer | Blueprint Medicines Corp (BPMC) | 15-Mar-24 | Planned Option Sale | 1,600 | $87.76 | $140,413.00 | (8%) 19.46K to 17.86K | |
| 19-Mar-24 5:11 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 15-Mar-24 | Option Exercise | 5,000 | $36.05 | $180,250.00 | 9% 56.02K to 61.02K | |
| 19-Mar-24 5:11 PM View: | Landsittel Michael Chief Financial Officer | Blueprint Medicines Corp (BPMC) | 15-Mar-24 | Sale (Planned) | 8,734 | $87.78 | $766,693.00 | (16%) 56.02K to 47.29K |
